USE OF MOXONIDINE FOR POSTMYOCARDIAL INFARCTION TREATMENT

摘要

The use of moxonidine and its physiologically compatible acid addition salts for the manufacture of pharmaceutical preparations for the treatment of myocardial damage secondary to myocardial infarction is described. Pharmaceutical preparations containing moxonidine and its physiologically compatible acid addition salts are suitable for use in acute myocardial infarction and/or postmyocardial infarction management. In addition to a beneficial influence, promoting recovery and/or rehabilitation, on the myocardial status following myocardial infarction, moxonidine and its physiologically compatible acid addition salts, especially when used in the management of postmyocardial infarction patients in the chronic stage, also show a preventive effect against the progression of heart failure after myocardial infarction.